BioCentury | Jan 27, 2014
Company News

Celesio deal

...Investor Elliott Asset Management LLC has increased its Celesio stake to 24.08% from 19.11% as of...
...company McKesson Corp. (NYSE:MCK, San Francisco, Calif.) announced plans to acquire the 50.01% stake in Celesio...
...and outstanding convertible bonds of Celesio. McKesson said the deal, which included the assumption of Celesio's...
BioCentury | Nov 4, 2013
Company News

Celesio, Franz Haniel & Cie., McKesson Corp. deal

...Healthcare services and IT company McKesson plans to acquire Haniel's 50.01% stake in Celesio for €23...
...The company expects to obtain operational control of Celesio in fiscal 2015, at which point Celesio...
...McKesson's Distribution Solutions segment. Celesio provides logistics and services to the pharmaceutical and healthcare sectors. Celesio AG...
BioCentury | Oct 30, 2006
Company News

Celesio AG, Ipsen sales and marketing update

...FDA for the product this quarter. TRCA expects to launch Somatuline Autogel in early 2007. Celesio AG...
BioCentury | Oct 9, 2006
Company News

Celesio AG, TopoTarget sales and marketing update

...in Europe. The topoisomerase II inhibitor is approved to treat accidental extravasation of anthracycline chemotherapeutics. Celesio AG...
Items per page:
1 - 4 of 4
BioCentury | Jan 27, 2014
Company News

Celesio deal

...Investor Elliott Asset Management LLC has increased its Celesio stake to 24.08% from 19.11% as of...
...company McKesson Corp. (NYSE:MCK, San Francisco, Calif.) announced plans to acquire the 50.01% stake in Celesio...
...and outstanding convertible bonds of Celesio. McKesson said the deal, which included the assumption of Celesio's...
BioCentury | Nov 4, 2013
Company News

Celesio, Franz Haniel & Cie., McKesson Corp. deal

...Healthcare services and IT company McKesson plans to acquire Haniel's 50.01% stake in Celesio for €23...
...The company expects to obtain operational control of Celesio in fiscal 2015, at which point Celesio...
...McKesson's Distribution Solutions segment. Celesio provides logistics and services to the pharmaceutical and healthcare sectors. Celesio AG...
BioCentury | Oct 30, 2006
Company News

Celesio AG, Ipsen sales and marketing update

...FDA for the product this quarter. TRCA expects to launch Somatuline Autogel in early 2007. Celesio AG...
BioCentury | Oct 9, 2006
Company News

Celesio AG, TopoTarget sales and marketing update

...in Europe. The topoisomerase II inhibitor is approved to treat accidental extravasation of anthracycline chemotherapeutics. Celesio AG...
Items per page:
1 - 4 of 4